26B-4-513. Coprescription guidelines.
109 words·~1 min read·
/ut/title-26b/chapter-4/26b-4-513A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Effective 5/6/2026
26B-4-513. Coprescription guidelines.
(1)As used in this section:
(a)"Controlled substance prescriber" means the same as that term is defined in Section 58-37-303 .
(b)"Coprescribe" means to issue a prescription for an opiate antagonist with a prescription for an opiate.
(2)The department shall, in consultation with the Medical Licensing Board created in Section 58-67-201 , and the Division of Professional Licensing created in Section 58-1-103 , establish by rule, made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, scientifically based guidelines for controlled substance prescribers to coprescribe an opiate antagonist to a patient.
Amended by Chapter 362 , 2026 General Session